00003-7125 OPDUALAG - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00003-7125

Brand Name:

OPDUALAG

Generic Name:

nivolumab and relatlimab-rmbw

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: NIVOLUMAB

Strength: 12.0

Unit: mg/mL

Name: RELATLIMAB

Strength: 4.0

Unit: mg/mL

Packages:

Code: 00003-7125-11

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE

Effective Date: March 18, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Monoclonal Antibody

Minor Class:

PD-1

LAG3

Orphan Drug Designation:

Status:

In Use